|
ZNF828 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.22835116814713E-14 |
| Normal-vs-Stage2 |
3.67869999999826E-05 |
| Normal-vs-Stage3 |
3.64930308194289E-13 |
| Normal-vs-Stage4 |
1.25459642674741E-11 |
| Stage1-vs-Stage2 |
1.895590E-01 |
| Stage1-vs-Stage3 |
2.299000E-01 |
| Stage1-vs-Stage4 |
1.001560E-01 |
| Stage2-vs-Stage3 |
5.488400E-02 |
| Stage2-vs-Stage4 |
3.028100E-02 |
| Stage3-vs-Stage4 |
4.975000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22124532708767E-15 |
| Normal-vs-AfricanAmerican |
1.52196999999576E-05 |
| Normal-vs-Asian |
8.43959999996535E-07 |
| Caucasian-vs-AfricanAmerican |
7.570600E-01 |
| Caucasian-vs-Asian |
2.551000E-01 |
| AfricanAmerican-vs-Asian |
6.353400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.62883073484954E-14 |
| Normal-vs-Female |
1.65101265992007E-12 |
| Male-vs-Female |
1.088980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.51088039249225E-12 |
| Normal-vs-Age(41-60Yrs) |
5.33906252542238E-13 |
| Normal-vs-Age(61-80Yrs) |
3.05160341440569E-11 |
| Normal-vs-Age(81-100Yrs) |
4.008200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.979600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.741800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.362800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.855600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.079800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.804600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.332420E-02 |
| Classical-VS-Follicular |
2.243400E-01 |
| Classical-VS-Other |
8.376200E-02 |
| Classical-VS-Normal |
2.2012391909243E-12 |
| Tall-VS-Follicular |
2.325200E-01 |
| Tall-VS-Other |
3.764800E-01 |
| Tall-VS-Normal |
4.13480361061147E-11 |
| Follicular-VS-Other |
2.480400E-01 |
| Follicular-VS-Normal |
4.70529948337628E-10 |
| Other-VS-Normal |
8.39880000000903E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.69801975100381E-12 |
| Normal-vs-N1 |
3.07742720195847E-12 |
| N0-vs-N1 |
2.504400E-02 |
|
|
